A detailed history of Sig Brokerage, LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Sig Brokerage, LP holds 34,502 shares of ALT stock, worth $143,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,502
Holding current value
$143,873
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$3.38 - $4.76 $116,616 - $164,229
34,502 New
34,502 $130 Million

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $204M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Sig Brokerage, LP Portfolio

Follow Sig Brokerage, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sig Brokerage, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sig Brokerage, LP with notifications on news.